What You Need to Know About Clinical Trials for Biotech Stocks

Let’s face it...biotech stocks are difficult to understand when you’re first starting out. Biotech stocks are volatile, and your account could suffer, if you don’t know what you’re looking for or...

Here’s What You Need to Know About Omeros’ Rise

Omeros Corporation (NASDAQ:OMER) ended the up nearly 15%, after the U.S. Food and Drug Administration (FDA) granted breakthrough therapy designation today. Let's get right into the catalyst and discuss some reasons...

GTx Shares Nearly Doubles Following Announcement of Phase II Proof-of-Concept Trial Data

GTx, Inc. (NASDAQ:GTXI) shares ended the day up over 90% due to the company’s announcement of its release of preliminary clinical data from its open-label, ongoing Phase II clinical trial of...
XBIT

XBiotech Plummets Over 60% After Discontinuation of Phase III Study, Here’s What You Need...

XBiotech Inc(NASDAQ: XBIT) shares were down over 60% today, after the company filed an SEC Form 8-K Filing shortly before the close. Now, the stock plummeted primarily due to its announcement...

NewLink Genetics Shares Plummet to Over Five-Year Lows Today, and Here’s What You Need...

NewLink Genetics Corp (NASDAQ:NLNK) shares closed down over 40% today, and NLNK hit levels it hasn’t seen in over five years, following the company’s business update conference call during the pre-market....
Synergy

Here’s Why Synergy Pharma Shares Soar 10% Today

Synergy Pharmaceuticals (NASDAQ: SGYP) shares ended the day up over 10% after Cantor Fitzgerald initiated coverage on SGYP yesterday. Check out the daily chart on SGYP. Source: TradingView Let's take a look at...

XBiotech Extending Yesterday’s Gains, After Phase III Findings

XBiotech Inc (NASDAQ: XBIT) shares ended the day up over 9%, and extended its more than 25% gain yesterday. Now, this move could be attributed to the company's presentation of data...

Pieris Pharmaceuticals Appoints Industry Expert to Board of Directors

The Board of Directors is one of the most important elements of a publicly-traded company, as the board makes key decisions regarding major company issues or corporate actions. That said, when...

Prana Biotechnology (NASDAQ:PRAN) Potential Sympathy Play

Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) shares were up 13.10% today. However, there were no company-related catalysts that may have sparked this move. This move may be due to traders buying in...
Pharmaceuticals

Sangamo Therapeutics Soars After Q1 2017 Results and Strategic Collaboration

It’s earnings season, and traders are focused closely on what companies say in their press release. Now, this gives companies a chance to show investors how they performed in the reported...